×
Product Info Description
Product Info Description
Strength: 12 mg CAS: Tesamorelin: 218949-48-5 / Ipamorelin: 170851-70-4 Chemical Formula: Tesamorelin: C221H366N72O67S Ipamorelin: C38H49N9O5 Molecular weight: Tesamorelin: C221H366N72O67S Ipamorelin: C38H49N9O5 Peptide Sequence: Tesamorelin: 5136 g/mol Ipamorelin: 711.9 g/mol Synonyms: Tesamorelin: Trans-3-hexenoyl-Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Val Leu Gly Gln Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg Gln Gln Gly Glu Ser Asn Gln Glu Arg Gly Ala Arg Ala Arg Leu NH2 Ipamorelin: Aib-His-D-2Nal-D-Phe-Lys-NH2 Storage: Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light. Shelf life: 24 months from the manufacturing date.
The 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) blend is used in laboratory research to study complementary GHRH/GHS-R signaling pathways and growth hormone-related endocrine interactions. Researchers examine pulse-response behavior, metabolic signaling patterns, and peptide pathway comparisons under controlled experimental conditions. For laboratory research use only.
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
Browse Products
INFORMATION
What is 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg)?
2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) is a two-peptide research blend commonly used to study the endocrine and growth hormone pathways. In laboratory settings, these peptides support experimental designs exploring receptor-driven signaling, pathway interactions, and downstream biomarker readouts in controlled models.
Tesamorelin is a stabilized GHRH (growth hormone–releasing hormone) analog, while Ipamorelin is a ghrelin (GHS-R) receptor agonist peptide often included in growth hormone secretagogue research.
Product Specifications
CAS Numbers:
Tesamorelin: 218949-48-5 Ipamorelin: 170851-70-4
Peptide Sequences:
Tesamorelin: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 Ipamorelin: Aib–His-D-2Nal-D-Phe-Lys
Molecular Formulas:
Tesamorelin: C221H366N72O67S Ipamorelin: C38H49N9O5
Molecular Weights:
Tesamorelin: 5136 g/mol Ipamorelin: 711.9 g/mol
Synonyms:
Tesamorelin: TH9507 Ipamorelin: NNC 26-0161
Category: Peptides
Subcategory: Muscle Growth & Performance Peptides Purity: ≥99% (use lot-specific COA for the exact value) Packaging Format: 1 vial (Tesamorelin (10mg) + Ipamorelin (2mg)) Storage Conditions: Store at -20°C, avoid light exposure
Key Characteristics of 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg)
Complementary Peptides: A blend of GHRH-analog (Tesamorelin) and GHS-R agonist (Ipamorelin) peptides, frequently used in growth-hormone pathway studies. Defined Sequences: Supported by CAS numbers and molecular structure records for reproducible experimental documentation. Reproducibility: Useful for controlled signaling studies where researchers track receptor-linked readouts and downstream biomarkers over time. Assay Work: Ideal for method development, pathway profiling, and comparative experiments where standardized materials are crucial.
How 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) Supports Research
This peptide blend is used in research settings to investigate growth-hormone–related endocrine signaling. Tesamorelin, as a stabilized analog of human GHRH, engages the GHRH receptor pathway, while Ipamorelin, a selective growth hormone secretagogue, acts through the ghrelin/GHS receptor system. Together, they provide researchers with tools to explore receptor-mediated signaling and downstream experimental readouts in controlled models.
Research Applications & Usage Information
2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) is commonly used in research for:
Endocrine Signaling Pathway Studies: Mapping receptor activation patterns and downstream biomarkers in experimental systems. Receptor Activity and Pathway Profiling: Comparative designs evaluating GHRH vs. GHS-R–linked signaling behavior. Gene/Protein Marker Workflows: Tracking changes in selected signaling markers after experimental exposure (model-dependent). Assay Development and Validation: Using defined peptide tools to benchmark sensitivity, repeatability, and measurement consistency. Mechanistic Studies: Research on growth hormone secretagogues, including ghrelin receptor agonist signaling.
Note: This material is intended for laboratory research use only. Study methods and models vary by institution and protocol.
Handling and Storage Recommendations
Store at -20°C and protect from light (keep in original packaging or a light-limiting container). Avoid repeated freeze–thaw cycles. Keep the vial tightly closed and handle it using clean laboratory techniques to minimize contamination. Follow standard PPE practices and your facility’s chemical hygiene, labeling, and disposal procedures.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
National Center for Biotechnology Information. PubChem Compound Summary for CID 16137828, Tesamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin. National Center for Biotechnology Information. PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. doi:10.1530/eje.0.1390552 Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010;95(9):4291-4304. doi:10.1210/jc.2010-0490 Stanley TL, Grinspoon SK. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies. Growth Horm IGF Res. 2015;25(2):59-65. doi:10.1016/j.ghir.2014.12.005
What is 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg)?
2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) is a two-peptide research blend commonly used to study the endocrine and growth hormone pathways. In laboratory settings, these peptides support experimental designs exploring receptor-driven signaling, pathway interactions, and downstream biomarker readouts in controlled models.
Tesamorelin is a stabilized GHRH (growth hormone–releasing hormone) analog, while Ipamorelin is a ghrelin (GHS-R) receptor agonist peptide often included in growth hormone secretagogue research.
Product Specifications
CAS Numbers:
Tesamorelin: 218949-48-5 Ipamorelin: 170851-70-4
Peptide Sequences:
Tesamorelin: Trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 Ipamorelin: Aib–His-D-2Nal-D-Phe-Lys
Molecular Formulas:
Tesamorelin: C221H366N72O67S Ipamorelin: C38H49N9O5
Molecular Weights:
Tesamorelin: 5136 g/mol Ipamorelin: 711.9 g/mol
Synonyms:
Tesamorelin: TH9507 Ipamorelin: NNC 26-0161
Category: Peptides
Subcategory: Muscle Growth & Performance Peptides Purity: ≥99% (use lot-specific COA for the exact value) Packaging Format: 1 vial (Tesamorelin (10mg) + Ipamorelin (2mg)) Storage Conditions: Store at -20°C, avoid light exposure
Key Characteristics of 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg)
Complementary Peptides: A blend of GHRH-analog (Tesamorelin) and GHS-R agonist (Ipamorelin) peptides, frequently used in growth-hormone pathway studies. Defined Sequences: Supported by CAS numbers and molecular structure records for reproducible experimental documentation. Reproducibility: Useful for controlled signaling studies where researchers track receptor-linked readouts and downstream biomarkers over time. Assay Work: Ideal for method development, pathway profiling, and comparative experiments where standardized materials are crucial.
How 2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) Supports Research
This peptide blend is used in research settings to investigate growth-hormone–related endocrine signaling. Tesamorelin, as a stabilized analog of human GHRH, engages the GHRH receptor pathway, while Ipamorelin, a selective growth hormone secretagogue, acts through the ghrelin/GHS receptor system. Together, they provide researchers with tools to explore receptor-mediated signaling and downstream experimental readouts in controlled models.
Research Applications & Usage Information
2X Blend: Tesamorelin (10mg) + Ipamorelin (2mg) is commonly used in research for:
Endocrine Signaling Pathway Studies: Mapping receptor activation patterns and downstream biomarkers in experimental systems. Receptor Activity and Pathway Profiling: Comparative designs evaluating GHRH vs. GHS-R–linked signaling behavior. Gene/Protein Marker Workflows: Tracking changes in selected signaling markers after experimental exposure (model-dependent). Assay Development and Validation: Using defined peptide tools to benchmark sensitivity, repeatability, and measurement consistency. Mechanistic Studies: Research on growth hormone secretagogues, including ghrelin receptor agonist signaling.
Note: This material is intended for laboratory research use only. Study methods and models vary by institution and protocol.
Handling and Storage Recommendations
Store at -20°C and protect from light (keep in original packaging or a light-limiting container). Avoid repeated freeze–thaw cycles. Keep the vial tightly closed and handle it using clean laboratory techniques to minimize contamination. Follow standard PPE practices and your facility’s chemical hygiene, labeling, and disposal procedures.
Research Use Only Notice
This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
References
National Center for Biotechnology Information. PubChem Compound Summary for CID 16137828, Tesamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Tesamorelin. National Center for Biotechnology Information. PubChem Compound Summary for CID 9831659, Ipamorelin. https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. doi:10.1530/eje.0.1390552 Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010;95(9):4291-4304. doi:10.1210/jc.2010-0490 Stanley TL, Grinspoon SK. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies. Growth Horm IGF Res. 2015;25(2):59-65. doi:10.1016/j.ghir.2014.12.005